Dr. Jerome Jourquin joined Susan G. Komen® in January of 2011 as a member of the team managing the money provided to breast cancer researchers around the world. In 2015, he became Manager, Scientific Programs, a position in which he oversees the Komen Scholars, a group of breast cancer research and advocacy leaders guiding Komen as advisors. He also co-leads Komen’s Big Data for Breast Cancer (BD4BC) Initiative that aims at using big data to fuel scientific discoveries and accelerate the delivery of equitable, patient-focused care. Dr. Jourquin also works closely with Komen’s nonprofits partners to assess programs and other partnerships aligning with Komen’s Bold Goal of reducing the number of breast cancer deaths in the U.S. by 50% by 2026. Committed to the Nashville community where he is based, Dr. Jourquin sits on the Race for the Cure® Planning Committee, serves on the Board of Directors of St. Luke’s Community House and is the treasurer of the Alliance Française of Nashville.
Prior to joining Komen, Dr. Jourquin completed in 2010 a Masters in Bioinformatics at Vanderbilt University, where he developed GLAD4U (http://bioinfo.vanderbilt.edu/glad4u/), a National Library of Medicine-awarded web-service designed to build prioritized gene lists based on user queries. With a particular interest in data mining and data sharing, Dr. Jourquin was also part of a multidisciplinary team of experimentalists, mathematicians, engineers, and bioinformaticists studying breast cancer invasion at Vanderbilt. Dr. Jourquin, a French native, earned a Ph.D. in Neurosciences from the University of Aix-Marseilles (2003) and a Master in Cell Biology and Animal Physiology from the University of Paris 7 – Denis Diderot (1997). In addition to authoring a book chapter on laminins and cancer, his research studies have been published in various scientific journals.